BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26825102)

  • 1. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
    Majchrzak K; Nelson MH; Bailey SR; Bowers JS; Yu XZ; Rubinstein MP; Himes RA; Paulos CM
    Cancer Immunol Immunother; 2016 Mar; 65(3):247-59. PubMed ID: 26825102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inducible costimulator augments Tc17 cell responses to self and tumor tissue.
    Nelson MH; Kundimi S; Bowers JS; Rogers CE; Huff LW; Schwartz KM; Thyagarajan K; Little EC; Mehrotra S; Cole DJ; Rubinstein MP; Paulos CM
    J Immunol; 2015 Feb; 194(4):1737-47. PubMed ID: 25576595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.
    Nanjappa SG; Heninger E; Wüthrich M; Gasper DJ; Klein BS
    PLoS Pathog; 2012; 8(7):e1002771. PubMed ID: 22829762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a mutation in IFN-γ receptor 2 (IFNGR2) in human cells on the generation of Th17 cells in memory T cells.
    Holzer U; Reinhardt K; Lang P; Handgretinger R; Fischer N
    Hum Immunol; 2013 Jun; 74(6):693-700. PubMed ID: 23459074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
    Saxena A; Desbois S; Carrié N; Lawand M; Mars LT; Liblau RS
    J Immunol; 2012 Sep; 189(6):3140-9. PubMed ID: 22904307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter.
    Satoh T; Tajima M; Wakita D; Kitamura H; Nishimura T
    Eur J Immunol; 2012 Sep; 42(9):2329-42. PubMed ID: 22674086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.
    Eysteinsdóttir JH; Sigurgeirsson B; Ólafsson JH; Fridriksson T; Agnarsson BA; Davíðsson S; Valdimarsson H; Lúðvíksson BR
    Scand J Immunol; 2013 Dec; 78(6):529-37. PubMed ID: 24111693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of stromal mast cells in the modification of CD4+CD25+Foxp³ regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor].
    Starska K; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw (Online); 2010 Aug; 64():408-16. PubMed ID: 20966498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc17 Cells in Immunity and Systemic Autoimmunity.
    Liang Y; Pan HF; Ye DQ
    Int Rev Immunol; 2015; 34(4):318-31. PubMed ID: 25259411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNγ cells.
    Nanjappa SG; McDermott AJ; Fites JS; Galles K; Wüthrich M; Deepe GS; Klein BS
    PLoS Pathog; 2017 May; 13(5):e1006356. PubMed ID: 28542595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ- and IL-17-producing CD8
    Ohkuri T; Kosaka A; Ikeura M; Salazar AM; Okada H
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34193567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
    Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer.
    Song L; Ma S; Chen L; Miao L; Tao M; Liu H
    Cancer Sci; 2019 Jul; 110(7):2100-2109. PubMed ID: 31100180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.